The agency said it will work to develop multiple monoclonal antibodies, which help block a virus from infecting human cells.
Regeneron previously worked on a similar treatment for Ebola and MERS.
Read the full news release here.
More articles on pharmacy:
Walgreens pays $7.5M to resolve claims an employee impersonated a pharmacist
SwedishAmerican opens ScriptCenter, a self-serve pharmacy kiosk
Walgreens CEO talks strategy, skips buyout speculation at annual meeting
Next Up in Pharmacy
-
Democrats won majorities in both the House and Senate in the Nov. 3 midterms, giving the party control of Congress…
-
Hartford, Conn.-based Hartford HealthCare has bought a former Sam’s Club in Manchester, Conn., for $17.4 million to use as a…
-
Three biotechnology trade groups filed a lawsuit Nov. 6 challenging CMS’ Global Benchmark for Efficient Drug Pricing Model, known as…
Join the 500,000+ healthcare executives who start their day with Becker's
Becker's Hospital Review Newsletter is sent Monday–Sunday.
